| 8.18 Delayed Data As of May 17 |  -0.12 / -1.45%Today’s Change | 5.75 Today|||52-Week Range 14.59 | +16.69% Year-to-Date |
| Previous close | 8.30 |
| Today’s open | 8.19 |
| Day’s range | 8.06 - 8.24 |
| Volume | 20,197 |
| Average volume (3 months) | 62,662 |
| Market cap | $207.7M |
| Earnings growth (last year) | +66.20% |
| Earnings growth (this year) | -10.46% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +3.11% |
| P/E ratio | NM |
| Price/Sales | 66.44 |
| Price/Book | 1.67 |
| Today’s change | Today’s % change | |
|---|---|---|
| CGENCompugen Ltd | +0.05 | +1.47% |
| TOCATocagen Inc | 0.00 | 0.00% |
| PFNXPfenex Inc | -0.15 | -2.17% |
| SLDBSolid Biosciences In... | -0.14 | -2.27% |
| Next reporting date | August 7, 2019 |
| EPS forecast (this quarter) | -$0.55 |
| Annual revenue (last year) | $2.5M |
| Annual profit (last year) | -$48.4M |
| Net profit margin | -1,922.02% |
Sector Health Technology |
Industry Biotechnology |
President, CEO, Director & Chief Medical Officer Aoife M. Brennan |
Chief Financial & Accounting Officer Todd Shegog |
Corporate headquarters Cambridge, Massachusetts |
